![Stephen Webster](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stephen Webster
Directeur/Membre du Conseil chez
CULLINAN THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Stephen W.
Webster was the founder of Neuronyx, Inc., founded in 2000, where the title held was President & Chief Executive Officer from 2000 to 2006.
Current jobs include Director at Nuron Biotech, Inc.; Independent Director at NextCure, Inc. since 2019; Director at Imvax, Inc. since 2023; Director at Spark Therapeutics UK Ltd. since 2016; Independent Director at Cullinan Therapeutics, Inc. since 2020; and Independent Director at Eloxx Pharmaceuticals, Inc. starting in 2026.
Former jobs include Chairman at TCR² Therapeutics, Inc. from 2022 to 2023; Independent Director at HearUSA, Inc. from 2011 to 2012; Managing Director-Healthcare Investment Banking at Broadpoint.
Gleacher Securities; Director-Investment Banking Division at PaineWebber, Inc. in 2000; Managing Director-Investment Banking Division at Broadpoint Securities, Inc. from 2007 to 2008; Director at Life Sciences Pennsylvania; Independent Director at Viking Therapeutics, Inc. from 2014 to 2020; Independent Director at Cullinan Oncology LLC; Director at Triplet Therapeutics, Inc.; Independent Director at Nabriva Therapeutics Plc; Independent Director at Gritstone bio, Inc. from 2024 to 2025; Chief Financial Officer & Senior Vice President at Adolor Corp.
from 2010 to 2011; Chief Financial Officer & Senior Vice President at Optimer Pharmaceuticals LLC from 2012 to 2013; Member-Supervisory Board at Nabriva Therapeutics GmbH from 2016 to 2017; and Chief Financial & Accounting Officer at Spark Therapeutics, Inc. from 2014 to 2019.
Education includes an undergraduate degree from Dartmouth College conferred in 1983 and an MBA from The Wharton School of the University of Pennsylvania.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
NEXTCURE, INC. -.--% | 18/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| 08/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Stephen Webster
| Sociétés | Poste | Début |
|---|---|---|
| NEXTCURE, INC. | Directeur/Membre du Conseil | 01/04/2019 |
| CULLINAN THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/09/2020 |
| ELOXX PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 27/05/2026 |
ImVax, Inc.
 ImVax, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Directeur/Membre du Conseil | 06/09/2023 |
Spark Therapeutics UK Ltd.
 Spark Therapeutics UK Ltd. Medical/Nursing ServicesHealth Services Provides health care services | Directeur/Membre du Conseil | 03/08/2016 |
Nuron Biotech, Inc.
 Nuron Biotech, Inc. BiotechnologyHealth Technology Markets and develops vaccines for the prevention and treatment of infectious diseases | Directeur/Membre du Conseil | - |
Anciens postes connus de Stephen Webster
| Sociétés | Poste | Fin |
|---|---|---|
| GRITSTONE BIO, INC. | Directeur/Membre du Conseil | 04/04/2025 |
| TCR2 THERAPEUTICS INC. | Président | 01/06/2023 |
| VIKING THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/01/2020 |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Stephen Webster
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
97
Relations au 1er degré
24
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 24 |
|---|---|
HearUSA, Inc.
 HearUSA, Inc. Medical DistributorsDistribution Services Distributes audio-logical products and provides hearing impaired services | Distribution Services |
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Neuronyx, Inc.
 Neuronyx, Inc. Medical SpecialtiesHealth Technology Develops and distributes bone marrow derived stem cells | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Broadpoint.Gleacher Securities
 Broadpoint.Gleacher Securities Investment Banks/BrokersFinance Provides brokerage services | Finance |
PaineWebber, Inc.
 PaineWebber, Inc. Investment Banks/BrokersFinance Provides stock brokerage and asset management services | Finance |
Broadpoint Securities, Inc.
 Broadpoint Securities, Inc. Investment Banks/BrokersFinance Provides broker-dealer and investment banking services | Finance |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Provides pharmaceutical research and development services | Health Technology |
Life Sciences Pennsylvania
 Life Sciences Pennsylvania Miscellaneous Commercial ServicesCommercial Services Provides consulting services to biosciences industry | Commercial Services |
Nuron Biotech, Inc.
Nuron Biotech, Inc. BiotechnologyHealth Technology Markets and develops vaccines for the prevention and treatment of infectious diseases | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Viking Therapeutics, Inc.
 Viking Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for metabolic and endocrine disorders | Health Technology |
Gritstone bio, Inc.
 Gritstone bio, Inc. Pharmaceuticals: MajorHealth Technology Develops immunotherapies for cancer | Health Technology |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Nabriva Therapeutics Plc
 Nabriva Therapeutics Plc Pharmaceuticals: MajorHealth Technology Engages in the research, development, and commercialization of novel anti-infective agents | Health Technology |
ImVax, Inc.
ImVax, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
Cullinan Oncology LLC
 Cullinan Oncology LLC Financial ConglomeratesFinance Provides investment services for cancer treatments | Finance |
Eloxx Pharmaceuticals, Inc.
 Eloxx Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics to treat cystic fibrosis, inherited retinal disorders and other diseases | Health Technology |
Spark Therapeutics UK Ltd.
Spark Therapeutics UK Ltd. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Triplet Therapeutics, Inc.
 Triplet Therapeutics, Inc. Medical/Nursing ServicesHealth Services Develops therapy for huntington's , myotonic dystrophy, spin cerebellar ataxias and repeated expansion diseases | Health Services |
Cullinan Oncology, Inc.
 Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
